
Home – Amarin Corp
Nov 9, 2025 · Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. Amarin is relentless in its pursuit of scientific …
Amarin Corporation - Wikipedia
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. [1] The company develops and …
Amarin Corporation plc (AMRN) Stock Price, News, Quote & History ...
Find the latest Amarin Corporation plc (AMRN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Amarin Corporation - LinkedIn
Amarin is a global pharmaceutical company committed to reducing the cardiovascular disease (CVD) burden for patients and communities and to advancing the science of cardiovascular care around the...
AMRN Stock Price | Amarin Corp. PLC ADR Stock Quote (U.S.: Nasdaq ...
Dec 26, 2025 · Shares of Amarin Corp. hiked up 5.4% in premarket trading Monday, after the drug maker said it would reduce its workforce by 40% as part of its plan to cut operating costs by $100 …
AMRN: Amarin Corporation PLC - Stock Price, Quote and News - CNBC
Get Amarin Corporation PLC (AMRN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Amarin Corporation (AMRN) Stock Price & Overview
5 days ago · A detailed overview of Amarin Corporation plc (AMRN) stock, including real-time price, chart, key statistics, news, and more.
About Amarin – Amarin Corp
Amarin is focused on discovering, developing and delivering innovative treatments and new therapeutic approaches that can make a difference in CVD patients' lives.
Amarin Corporation PLC (AMRN) Stock Price & News - Google
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey.
Amarin Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 · Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.